SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer

Patients with high-grade serous ovarian cancer (HGSOC) have a very poor overall survival. Current therapeutic approaches do not bring benefit to all patients. Although genetic alterations and molecular mechanisms are well characterized, the molecular pathological conditions are poorly investigated....

Descripción completa

Detalles Bibliográficos
Autores principales: Koller, Stephanie, Kendler, Jonatan, Karacs, Jasmine, Wolf, Andrea, Kreuzinger, Caroline, Von Der Decken, Isabel, Mungenast, Felicitas, Mechtcheriakova, Diana, Schreiner, Wolfgang, Gleiss, Andreas, Jäger, Walter, Cacsire Castillo-Tong, Dan, Thalhammer, Theresia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465617/
https://www.ncbi.nlm.nih.gov/pubmed/36105223
http://dx.doi.org/10.3389/fphar.2022.946348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465617/
https://www.ncbi.nlm.nih.gov/pubmed/36105223
http://dx.doi.org/10.3389/fphar.2022.946348

Ejemplares similares